• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 5
  • 4
  • 2
  • 2
  • 1
  • Tagged with
  • 14
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
11

Změny v expresi membránových molekul CD200R, CD95, CD95L a solubilního CD200R regulujících zánětlivou odpověď u pacientů podstupujících kardiochirurgický zákrok / Changes in Expression of Membrane Molecules CD200R, CD95, CD95L, and Soluble CD200R Regulating inflammatory Responses in Patients Undergoing Cardiac Surgery

Holmannová, Drahomíra January 2017 (has links)
Cardiac surgery is known to initiate a complex physiological response with the immune system activation (SIRS), neurohormonal response, metabolic changes, coagulopathies etc. SIRS is triggered by tissue injury, myocardial ischemia, reperfusion, use of anaesthesia, cardioplegia, extracorporeal circuit etc. Excessive immune system activation is associated with progression of SIRS, life-threatening multi-organ dysfunction (MOD), and increased morbidity/mortality in the postoperative period. The immune system response is regulated and terminated by both cellular and humoral regulatory and inhibitory mechanisms including changes in expression of in our study monitored molecules: CD200/CD200R, sCD200R and CD95/CD95L. Methods: The study included the measurement the expression of CD95, CD95L, CD200R, and sCD200R molecules in granulocyte and monocyte populations in blood samples of 30 patients who underwent heart surgery using CPB. Samples collected before surgery, after surgery, and in the postoperative period (1st , 3rd , 7th day) were analysed by flow cytometry and sCD200R by ELISA. Results: We discovered a significant increase in the percentage of granulocytes expressing inhibitory molecule CD200R (from 5% to 17.8%) instantly after surgery. It might be presumed that these cells are less susceptible to...
12

An anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease

Varnum, Megan Marissa 03 November 2015 (has links)
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid-β peptide (Aβ) in the brain and intraneuronal hyperphosphorylated tau. Microglia in the brain adopt M1 (pro-inflammatory) or M2 (anti-inflammatory) phenotypes similar to peripheral monocytes. M1 microglia negatively affect neurogenesis and have reduced phagocytic capabilities whereas M2 microglia can enhance neurogenesis and support phagocytosis. Cluster of Differentiation-200 (CD200) is an anti-inflammatory glycoprotein physiologically expressed on neurons and lymphocytes, and its receptors (CD200R1 and CD200R3) are expressed on glia. Both AD patients and mouse models of AD show an age-related or Aβ-induced reduction in neural CD200 that may contribute to M1-skewing of microglia in AD. We hypothesize that CD200 skews microglia to an M2 phenotype, and that genetic over-expression of CD200 in transgenic mice expressing the Swedish familial AD mutation of human β-amyloid precursor protein (APP mice) can restore neurogenesis and enhance Aβ clearance in the hippocampus. In this study, we constructed a tetracycline-controlled transactivator-inducible adeno-associated virus serotype 2/1 expressing full-length CD200 (AAV2/1-CD200) or green fluorescent protein (AAV2/1- GFP). These were bilaterally injected into the hippocampi at 6 months of age, and mice were sacrificed at 12 months of age. AAV2/1-GFP-injected APP mice showed a reduction in number of proliferating neural stem cells (NSCs) by 65.0% and differentiating NSCs by 70.5% in the dentate gyrus compared to wild-type controls. AAV2/1-CD200 restored these neurogenic deficits to those of wild-type mouse levels. AAV2/1-CD200 reduced diffuse Aβ plaques in the hippocampal region by 65.5% compared to AAV2/1-GFP-injected APP mice, but did not alter thioflavin-S-positive compact plaques as measured by protein and immunohistochemical assays. In vitro studies demonstrated that CD200-stimulated microglia co-cultured in transwells increased differentiation and complexity of neural stem cells. CD200 also directly enhanced Aβ phagocytosis by microglia. CD200 enhanced expression of the adaptor protein TYRO protein tyrosine kinase binding protein (TYROBP), suggesting this may be the mechanism by which CD200 enhances phagocytosis of Aβ. Overall, the data presented here indicate that CD200 is a plausible therapeutic agent in patients with AD to enhance neural differentiation and microglial-mediated clearance of Aβ.
13

Změny v expresi membránových molekul CD200R, CD95, CD95L a solubilního CD200R regulujících zánětlivou odpověď u pacientů podstupujících kardiochirurgický zákrok / Changes in Expression of Membrane Molecules CD200R, CD95, CD95L, and Soluble CD200R Regulating inflammatory Responses in Patients Undergoing Cardiac Surgery

Holmannová, Drahomíra January 2017 (has links)
Cardiac surgery is known to initiate a complex physiological response with the immune system activation (SIRS), neurohormonal response, metabolic changes, coagulopathies etc. SIRS is triggered by tissue injury, myocardial ischemia, reperfusion, use of anaesthesia, cardioplegia, extracorporeal circuit etc. Excessive immune system activation is associated with progression of SIRS, life-threatening multi-organ dysfunction (MOD), and increased morbidity/mortality in the postoperative period. The immune system response is regulated and terminated by both cellular and humoral regulatory and inhibitory mechanisms including changes in expression of in our study monitored molecules: CD200/CD200R, sCD200R and CD95/CD95L. Methods: The study included the measurement the expression of CD95, CD95L, CD200R, and sCD200R molecules in granulocyte and monocyte populations in blood samples of 30 patients who underwent heart surgery using CPB. Samples collected before surgery, after surgery, and in the postoperative period (1st , 3rd , 7th day) were analysed by flow cytometry and sCD200R by ELISA. Results: We discovered a significant increase in the percentage of granulocytes expressing inhibitory molecule CD200R (from 5% to 17.8%) instantly after surgery. It might be presumed that these cells are less susceptible to...
14

CD200-CD200R Interaction in Tumor Immunity

Talebian, Fatemeh 20 June 2012 (has links)
No description available.

Page generated in 0.0319 seconds